{
    "code": "22000004",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=22000004",
    "time": "2021-11-12 03:26:15",
    "許可證字號": "衛署罕菌疫輸字第000004號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/04\/26",
    "發證\/登錄日期": "93\/04\/26",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA02200000406",
    "中文品名": "利甫蓋素濃縮注射液１毫克\/毫升",
    "英文品名": "REPLAGAL 1MG\/ML CONCENTRATION FOR SOLUTION FOR INFUSION",
    "適應症": "用於治療α-GALACTOSIDASE A缺乏患者(即FABRY DISEASE)，提供長期酵素補充治療。",
    "劑型": "270注射劑",
    "包裝": "3.5毫升\/小瓶 1小瓶\/盒裝 4小瓶\/盒裝 10小瓶\/盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "AGALSIDASE ALFA",
    "限制項目": "02輸　入",
    "申請商名稱": "1406701100  台灣武田藥品工業股份有限公司",
    "申請商地址": "台北市信義區松高路1號17樓",
    "主製造廠": [
        {
            "": "GERMANY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FNL0127000  DHL SUPPLY CHAIN (NETHERLANDS) B.V",
            "製造廠廠址": "BIJSTERHUIZEN 3142, WIJCHEN, 6604 LV, NETHERLANDS",
            "製造廠公司地址": "",
            "製造廠國別": "NETHERLANDS",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FUS0772000  SHIRE HUMAN GENETIC THERAPIES, Inc.",
            "製造廠廠址": "205 ALEWIFE BROOK PARKWAY, CAMBRIDGE, MA 02138, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        },
        {
            "製造廠名稱": "FUS0853000  SHIRE HUMAN GENETIC THERAPIES, INC.",
            "製造廠廠址": "400 SHIRE WAY LEXINGTON, MA 02421, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200095500",
            "成分名稱": "AGALSIDASE ALFA",
            "含量描述": "",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Replagal vial-108-03-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=22000004&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Replagal_EU202011TW01_TFDA_clean v2-110-09-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=22000004&Seq=006&Type=9"
        },
        {
            "title": "Replagal Carton TW_TAKEDA_LEO_20191225_自行上傳版本-108-12-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=22000004&Seq=007&Type=8"
        },
        {
            "title": "220000040003-108-03-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=22000004&Seq=006&Type=8"
        },
        {
            "title": "220000040001-108-03-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=22000004&Seq=005&Type=8"
        },
        {
            "title": "Replagal Carton Taiwan-106-01-13.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=22000004&Seq=004&Type=8"
        }
    ]
}